SPARTA® is compatible with most common nanoparticle types used for diagnostic and therapeutic purposes. We have extensive expertise in the analysis of a diverse range of particles, including those listed below, and are always keen to expand our range with bespoke solutions to benefit your unique particle systems.
SPARTA Biodiscovery is proud to offer services to many parties from academic groups and new industry innovators as well as established pharmaceutical partners
Our diverse and multidisciplinary team of experts is at your disposal to aid in your R&D needs.
We offer analysis packages using our SPARTA® technology to offer you unprecedented insight into your formulations.
In addition to our SPARTA® technology, we offer complementary standard techniques such as dynamic light scattering (DLS) and nanoparticle tracking analysis (NTA).
We believe SPARTA® can play a key role in optimising both the R&D and QC aspects of the development of next-generation therapeutics. Please get in touch if you are interested in a bespoke longer-term collaboration.
SPARTA® meets the pharmaceutical and biotechnology industry's need for the individual analysis of nanoformulations by enabling accurate chemical analysis of nanoparticles in a compact bench-top product using next-generation innovation.